These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21560651)

  • 1. [Modeling damage of the mucous membrane of the gastrointestinal tract in rats].
    Trubitsyna IE; Drozdov VN; Tkachenko EV; Varvanina GG
    Eksp Klin Gastroenterol; 2011; (2):117-20. PubMed ID: 21560651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of NSAID effect on prostaglandine contents].
    Drozdov VN; Tkachenko EV; Varvanina GG; Trubitsyna IE
    Eksp Klin Gastroenterol; 2007; (5):77-80. PubMed ID: 18389602
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of E2 and F2alpha prostaglandins in development of erosive-ulcerative lesions of the gastroduodenal region].
    Varvanina GG; Tkachenko EV; Drozdov VN
    Eksp Klin Gastroenterol; 2009; (4):13-6. PubMed ID: 19960991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
    Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of non-steroidal anti-inflammatory drugs on small intestinal barrier function in rats].
    Zhang S; Lü B; Si JM; Chen FM; Meng LN; Wu WF; Yu LM
    Zhonghua Nei Ke Za Zhi; 2009 Jan; 48(1):44-7. PubMed ID: 19484977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological changes in the structure, regional blood circulation and content of the prostaglandins in the rats intestinal mucosa at different NSAIDS effects].
    Tkachenko EV; Varvanina GG; Droszdov VN; Trubitsina IE; Chikunova BZ
    Eksp Klin Gastroenterol; 2010; (3):71-3. PubMed ID: 20496793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
    Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
    Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins, NSAIDs, and cytoprotection.
    Wallace JL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):631-41. PubMed ID: 1516961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
    Ligumsky M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective COX-2 inhibitors and gastrointestinal mucosal injury: pharmacological and therapeutic considerations.
    Dajani EZ; Agrawal NM
    J Assoc Acad Minor Phys; 2000; 11(2-3):28-31. PubMed ID: 10953541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID-induced gastric mucosal damage.
    Semble EL; Wu WC
    Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemical protective mechanisms against non-steroidal anti-inflammatory drug induced G-I mucosal damage.
    Rainsford KD
    Acta Physiol Hung; 1989; 73(2-3):261-78. PubMed ID: 2512767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel.
    Schneider AR; Benz C; Riemann JF
    Endoscopy; 1999 Nov; 31(9):761-7. PubMed ID: 10604623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.